Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers

Area of Science:

• Oncology
• Gene Therapy
• Molecular Biology

Background:

• Adenoviral vector gene delivery shows promise for lung cancer treatment.
• Adenovirus serotype 5 (Ad5) vectors utilize the coxsackievirus adenovirus receptor (CAR) for cell entry.
• CAR expression levels influence lung cancer cell permissiveness and potentially proliferation.

Purpose of the Study:

• To investigate coxsackievirus adenovirus receptor (CAR) expression in various lung cancer subtypes.
• To determine the correlation between CAR expression and clinicopathological features.
• To assess the potential utility of Ad5-based vectors for gene delivery in different lung cancer types.

Main Methods:

• Analysis of archival lung cancer specimens.
• Immunohistochemical detection of CAR expression using CAR 72 antibodies.
• Correlation of CAR levels with lung cancer histology (squamous cell, small cell, adenocarcinoma) and grade.

Main Results:

• High CAR expression was prevalent in squamous cell (32/32) and small cell (5/5) lung cancers.
• Adenocarcinoma lung cancers showed variable CAR expression, with high levels in only 6 of 22 cases.
• CAR expression did not correlate with tumor grade and was absent in non-malignant alveolar cells.

Conclusions:

• Adenovirus serotype 5 (Ad5) vectors demonstrate potential for gene delivery in squamous cell and small cell lung cancers due to high CAR expression.
• The majority of adenocarcinoma lung cancers may not be suitable for Ad5 vector-mediated gene delivery because of low CAR expression.
• CAR expression levels are a critical factor in determining the efficacy of Ad5-based gene therapy for specific lung cancer subtypes.